Last reviewed · How we verify
Norethindrone Acetate-Ethinyl Estradiol — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Norethindrone Acetate-Ethinyl Estradiol (Norethindrone Acetate-Ethinyl Estradiol) — Elizabeth Austen Lawson.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Norethindrone Acetate-Ethinyl Estradiol TARGET | Norethindrone Acetate-Ethinyl Estradiol | Elizabeth Austen Lawson | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Norethindrone Acetate-Ethinyl Estradiol CI watch — RSS
- Norethindrone Acetate-Ethinyl Estradiol CI watch — Atom
- Norethindrone Acetate-Ethinyl Estradiol CI watch — JSON
- Norethindrone Acetate-Ethinyl Estradiol alone — RSS
Cite this brief
Drug Landscape (2026). Norethindrone Acetate-Ethinyl Estradiol — Competitive Intelligence Brief. https://druglandscape.com/ci/norethindrone-acetate-ethinyl-estradiol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab